文化大學機構典藏 CCUR:Item 987654321/26929
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47250/51116 (92%)
Visitors : 14576950      Online Users : 924
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/26929


    題名: AN INVESTOR'S PERSPECTIVE ON INFECTIOUS DISEASES AND THEIR INFLUENCE ON MARKET BEHAVIOR
    作者: Wang, YH (Wang, Yi-Hsien)
    Yang, FJ (Yang, Fu-Ju)
    Chen, LJ (Chen, Li-Je)
    貢獻者: Dept Banking & Finance
    關鍵詞: biotechnology industry
    infectious diseases
    investor's perspective
    abnormal returns
    stock performance
    risk factor
    market model
    日期: 2013
    上傳時間: 2014-03-03 11:20:56 (UTC+8)
    摘要: Recently, increasing number of infectious diseases has swept the world. The outbreak of a contagious disease not only affects the health and lives of people but also causes economic growth to stagnate. Business in the biotechnology industry is closely related to infectious diseases but what exactly is the information value of the outbreak of infectious disease on biotechnology? This study investigates how such outbreaks can affect the performance of biotechnology stocks. In the past 10 years, major statutory infectious diseases in Taiwan have included ENTEROVIRUS 71, DENGUE FEVER, SARS and H1N1. The empirical results indicate that there is a significant abnormal return on company shares in Taiwan's biotechnology industry because of statutory infectious epidemics. The relationship between the financial ratios of biotechnology companies and abnormal returns was analyzed as part of this research. The results show that the influence on R&D ratios, current ratios and assets are significant. Empirical findings reveal that the investors rationally measure operating conditions of the biotechnology companies during outbreaks of major infectious disease and adjust portfolio allocation accordingly.
    關聯: JOURNAL OF BUSINESS ECONOMICS AND MANAGEMENT Volume: 14 Special Issue: SI Supplement: 1 Pages: S112-S127
    顯示於類別:[Department of Banking & Finance ] periodical articles

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML454檢視/開啟


    在CCUR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©  2006-2025  - 回饋